2162 — Keymed Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Keymed Biosciences, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,525	3,175	2,719	2,156	1,924
Net Total Accounts Receivable
Net Total Receivables	13.6	7.44	36.8	69.5	101
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,582	3,310	2,940	2,466	2,423
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	306	596	911	1,075	1,299
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	3,934	3,932	3,883	3,767	4,218
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	112	380	314	748	836
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	283	592	897	1,292	1,443
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	3,651	3,340	2,986	2,475	2,774
Total Liabilities & Shareholders' Equity	3,934	3,932	3,883	3,767	4,218
Total Common Shares Outstanding